The U.S. Patent and Trademark Office has issued a patent on innovations that could improve therapies to repair cartilage damage. Dr. Stephen B. Trippel of the Indiana University School of Medicine created the molecules that are part of this innovation.
Articular cartilage damage is a major cause of disability in the form of arthritis and joint trauma. Because articular cartilage lacks the ability to effectively repair itself, repairing it is an unsolved clinical problem. A promising candidate for repair has several limitations, including being rapidly removed and slow diffusion into cartilage. New molecules from the Indiana University School of Medicine could address these drawbacks.
The innovation was disclosed to the IU Innovation and Commercialization Office. The mission of the office is to drive innovation to the market for the benefit of the public, the university and innovators for state, national and global commerce. IU personnel can disclose an invention online.